Literature DB >> 18589835

Omalizumab for patients with severe and therapy-refractory atopic eczema?

Christian Andres1, Benedetta Belloni, Martin Mempel, Johannes Ring.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18589835     DOI： 10.1007/s11882-008-0029-3

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN： 1529-7322            Impact factor:   4.806


× No keyword cloud information.
  11 in total

Review 1.  Maintenance of serum antibody levels.

Authors:  Rudolf A Manz; Anja E Hauser; Falk Hiepe; Andreas Radbruch
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

2.  Position paper on diagnosis and treatment of atopic dermatitis.

Authors:  U Darsow; J Lübbe; A Taïeb; S Seidenari; A Wollenberg; A M Calza; F Giusti; J Ring
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-05       Impact factor: 6.166

3.  Inefficient processing of mRNA for the membrane form of IgE is a genetic mechanism to limit recruitment of IgE-secreting cells.

Authors:  Alexander Karnowski; Gertrude Achatz-Straussberger; Cordula Klockenbusch; Gernot Achatz; Marinus C Lamers
Journal:  Eur J Immunol       Date:  2006-07       Impact factor: 5.532

4.  Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.

Authors:  Benedetta Belloni; Mahzad Ziai; Annick Lim; Brigitte Lemercier; Martin Sbornik; Stephan Weidinger; Christian Andres; Christina Schnopp; Johannes Ring; Rüdiger Hein; Markus Ollert; Martin Mempel
Journal:  J Allergy Clin Immunol       Date:  2007-10-22       Impact factor: 10.793

5.  Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.

Authors:  T Kakinuma; K Nakamura; M Wakugawa; H Mitsui; Y Tada; H Saeki; H Torii; A Asahina; N Onai; K Matsushima; K Tamaki
Journal:  J Allergy Clin Immunol       Date:  2001-03       Impact factor: 10.793

Review 6.  Safety and tolerability of omalizumab (Xolair), a recombinant humanized monoclonal anti-IgE antibody.

Authors:  Yamo M Deniz; Niroo Gupta
Journal:  Clin Rev Allergy Immunol       Date:  2005-08       Impact factor: 8.667

7.  Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis.

Authors:  B Kunz; A P Oranje; L Labrèze; J F Stalder; J Ring; A Taïeb
Journal:  Dermatology       Date:  1997       Impact factor: 5.366

8.  Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.

Authors:  DirkJan Hijnen; Marjolein De Bruin-Weller; Bert Oosting; Cristina Lebre; Esther De Jong; Carla Bruijnzeel-Koomen; Edward Knol
Journal:  J Allergy Clin Immunol       Date:  2004-02       Impact factor: 10.793

9.  Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005.

Authors:  Alain Taïeb; Jon Hanifin; Kevin Cooper; Jan D Bos; Genji Imokawa; Tim J David; Johannes Ring; Carlo Gelmetti; Alexander Kapp; Masutaka Furue; Yves de Prost; Ulf Darsow; Thomas Werfel; David Atherton; Arnold P Oranje
Journal:  J Allergy Clin Immunol       Date:  2006-02       Impact factor: 10.793

10.  The IgE repertoire in PBMCs of atopic patients is characterized by individual rearrangements without variable region of the heavy immunoglobulin chain bias.

Authors:  Annick Lim; Stephan Luderschmidt; Anke Weidinger; Christina Schnopp; Johannes Ring; Rüdiger Hein; Markus Ollert; Martin Mempel
Journal:  J Allergy Clin Immunol       Date:  2007-07-12       Impact factor: 10.793
View more
  4 in total

1.  IgE-mediated mast cell responses are inhibited by thymol-mediated, activation-induced cell death in skin inflammation.

Authors:  Joshua B Wechsler; Chia-Lin Hsu; Paul J Bryce
Journal:  J Allergy Clin Immunol       Date:  2014-01-31       Impact factor: 10.793

Review 2.  Monoclonal antibodies and other biologic agents in the treatment of asthma.

Authors:  Aidan A Long
Journal:  MAbs       Date:  2009-05-04       Impact factor: 5.857

Review 3.  Systemic Treatment of Adult Atopic Dermatitis: A Review.

Authors:  Matteo Megna; Maddalena Napolitano; Cataldo Patruno; Alessia Villani; Anna Balato; Giuseppe Monfrecola; Fabio Ayala; Nicola Balato
Journal:  Dermatol Ther (Heidelb)       Date:  2016-12-26

Review 4.  Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence.

Authors:  Andreas Wollenberg; Simon Francis Thomsen; Jean-Philippe Lacour; Xavier Jaumont; Slawomir Lazarewicz
Journal:  World Allergy Organ J       Date:  2021-03-19       Impact factor: 4.084
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.